Alaunos Therapeutics, Inc. (TCRT) Reports In-Line Q2 EPS

Alaunos Therapeutics, Inc. (NASDAQ: TCRT) reported Q2 EPS of ($0.04), in-line with the analyst estimate of ($0.04).

For earnings history and earnings-related data on Alaunos Therapeutics, Inc. (TCRT) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
• Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance